Bausch + Lomb to Engage at Citi Global Healthcare Conference

An update from Bausch + Lomb Corporation ( (BLCO) ) is now available.

Bausch + Lomb Corporation announced that its Chairman and CEO, Brent Saunders, along with Executive Vice President and CFO, Sam Eldessouky, will participate in a fireside chat at the 2025 Citi Global Healthcare Conference. This participation underscores the company’s active engagement with the healthcare investment community and highlights its ongoing strategic initiatives to strengthen its position in the eye health industry.

The most recent analyst rating on (BLCO) stock is a Hold with a $17.00 price target. To see the full list of analyst forecasts on Bausch + Lomb Corporation stock, see the BLCO Stock Forecast page.

Spark’s Take on BLCO Stock

According to Spark, TipRanks’ AI Analyst, BLCO is a Neutral.

Bausch + Lomb Corporation’s overall stock score is driven by its strong technical momentum and positive earnings call outlook, which are offset by weak financial performance and valuation concerns. The company’s challenges in profitability and cash flow, along with a negative P/E ratio, weigh heavily on its score. However, the positive momentum and strategic management highlighted in the earnings call provide some optimism for future performance.

To see Spark’s full report on BLCO stock, click here.

More about Bausch + Lomb Corporation

Bausch + Lomb Corporation is a global leader in eye health, focusing on helping people improve their vision and quality of life. The company offers a wide range of products, including contact lenses, prescription products, over-the-counter options, and surgical devices, with a strong commitment to innovation and enhancing eye care standards.

Average Trading Volume: 530,327

Technical Sentiment Signal: Buy

Current Market Cap: $5.53B

Learn more about BLCO stock on TipRanks’ Stock Analysis page.